MEDICINE DETAILS
Aimovig
Active ingredient: Erenumab
Neutral reference profile for an independent medicine-access consultancy enquiry about Aimovig (Erenumab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Aimovig used for?
Aimovig (erenumab) is indicated for use as once monthly preventive treatment for adults who suffer from migraines. This includes migraine subtypes: episodic and chronic that are defined respectively as 4 to 14 migraine days per month (episodic) and 15 or more headaches per month of which 8 are migraine days (chronic). [Please note that approvals in some countries may be for some subtypes and not all migraines.]
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Aimovig identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
70 mg · 1 pen Catalogue organisation: NOVARTIS Pharma GmbH
-
70 mg · 3 pens Catalogue organisation: NOVARTIS Pharma GmbH
-
140 mg · 1 pen Catalogue organisation: NOVARTIS Pharma GmbH
-
140 mg · 3 pens Catalogue organisation: NOVARTIS Pharma GmbH
OFFICIAL SOURCES
Check the Aimovig record at an official source.
Search for “Aimovig” or “Erenumab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Aimovig.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Aimovig
01What is Aimovig?＋
This directory record associates the brand name Aimovig with the active ingredient Erenumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Aimovig strengths and packs are recorded?＋
The catalogue currently shows: 70 mg · 1 pen; 70 mg · 3 pens; 140 mg · 1 pen; 140 mg · 3 pens. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Aimovig?＋
Catalogue records currently name: NOVARTIS Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Aimovig?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Aimovig, payment request, stock guarantee or binding offer.
06Can I buy Aimovig from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.